Pacific Biosciences (NASDAQ:PACB) reported its Q1 earnings results on Wednesday, May 4, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
Pacific Biosciences missed estimated earnings by 19.35%, reporting an EPS of $-0.37 versus an estimate of $-0.31.
Revenue was up $4.18 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.02 which was followed by a 4.39% increase in the share price the next day.
Here's a look at Pacific Biosciences's past performance:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.28 | -0.22 | -0.20 | -0.45 |
| EPS Actual | -0.30 | -0.23 | -0.21 | -0.45 |
| Revenue Estimate | 36.12M | 33.23M | 29.89M | 25.67M |
| Revenue Actual | 36.02M | 34.89M | 30.61M | 29.00M |
To track all earnings releases for Pacific Biosciences visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
